Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-24
2006-10-24
Tucker, Zachary C (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S248000, C514S249000, C514S255050, C514S259500, C514S266200, C514S269000, C514S306000, C514S307000, C514S309000, C514S312000, C514S314000, C514S343000, C514S367000, C514S368000, C514S369000, C514S372000, C514S373000, C514S375000, C514S376000, C514S379000, C514S380000, C514S390000, C514S394000, C514S395000, C514S397000, C514S405000, C514S407000, C544S235000, C544S237000, C544S238000, C544S239000, C544S282000, C544S287000, C544S288000, C544S316000, C544S319000, C544S349000, C544S354000, C544S408000, C546S
Reexamination Certificate
active
07125863
ABSTRACT:
Compounds according to formula (1), wherein R1is H or CN, X1is S, O, SO2or CH2, X2is CO, CH2or a covalent bond, Het is a nitrogen-containing heterocycle and n is 1–5 are new. The compounds of the invention are inhibitors of dipeptidyl peptidase IV. Pharmaceutical compositions of the compounds of the invention, or pharmaceutically acceptable salts thereof, are useful in the treatment of, inter alia, type 2 diabetes
REFERENCES:
patent: 5462928 (1995-10-01), Bachovchin et al.
patent: 6011155 (2000-01-01), Villhauer
patent: 2004/0167341 (2004-08-01), Haffner et al.
patent: 2004/0171848 (2004-09-01), Haffner et al.
patent: WO 98/19998 (1998-05-01), None
Evans, D. M. “Dipeptidyl Peptidase IV Inhibitors” Investigational Drugs Journal, vol. 5(6), pp. 577-585 (2002).
Bonnett et al, “Experiments towards the Synthesis of Corrins. Part 1. The Preparation and Reactions of Some delta-1-Pyrrolines. A Novel Proline Synthesis” Journal of the Chemical Society, pp. 2087-2093 (1959).
Davey et al, “The Synthesis and Ionisation Constants of Some Fluorenamines” Journal of the Chemical Society [Section C: Organic], pp. 120-123 (1967).
Sozen and Arici, “Hyperinsulinism and Its Interaction With Hyperandrogenism in Polycystic Ovary Syndrome” Obstetrical and Gynecological Survey, vol. 55(5), pp. 321-328 (2000).
Goodman & Gilman's The Pharmacological Basis of Therapeutics Tenth Edition, McGraw-Hill Medical Publishing Division © 2001, pp. 1541-1546.
Bengtsson et al, “Therapeutic Controversy—Treatment of Growth Hormone Deficiency in Adults” Journal of Clinical Endocrinology & Metabolism, vol. 85(3), pp 933-942 (2000).
Evans David Michael
Pitt Gary Robert William
Ferring BV
Foley & Lardner LLP
Tucker Zachary C
LandOfFree
Inhibitors of dipeptidyl peptidase IV does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of dipeptidyl peptidase IV, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of dipeptidyl peptidase IV will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3684429